SWITCH PATTERNS AND TOTAL COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIASIS

被引：0
|
作者：
Wu, J. [1 ]
Pelletier, C. [2 ]
Ung, B. [2 ]
Tian, M. [2 ]
Ni, Q. [2 ]
Curtis, J. R. [3 ]
机构：
[1] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
[2] Celgene Corp, Summit, NJ USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2523
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS23
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [41] PROBABILITY OF ACHIEVING TREATMENT TARGETS WITH APREMILAST MONOTHERAPY IN BIOLOGIC-NAIVE PSORIATIC ARTHRITIS PATIENTS IN ACTIVE WITH MODERATE AND HIGH BASELINE DISEASE ACTIVITY
    Nash, P.
    Richter, S.
    Jardon, S.
    Teng, L.
    Walsh, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1310 - 1311
  • [42] Health care resource utilization, health care costs, and dose escalation in biologic-naive psoriasis patients initiated on ustekinumab versus adalimumab
    Guerin, Annie
    Sundaram, Murali
    Gauthier, Genevieve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB236 - AB236
  • [43] Characteristics of patients with moderate-to-severe psoriasis treated with secukinumab in US clinical practice-A focus on biologic-naive and biologic-experienced patients
    Feldman, Steven
    Palmer, Jacqueline
    Djatche, Laurence
    Hur, Peter
    Zhao, Yang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB68 - AB68
  • [44] THE PSORIASIS STUDY OF HEALTH OUTCOMES (PSOHO) IN BIOLOGIC-NAIVE AND -EXPERIENCED PATIENTS: RESULTS FROM THE FIRST 217 PATIENTS
    Costanzo, A.
    Pinter, A.
    Lynde, C.
    Tsai, T. F.
    Schuster, C.
    Brnabic, A.
    Reed, C.
    Hill, J.
    Riedl, E.
    Radtke, M. A.
    VALUE IN HEALTH, 2020, 23 : S410 - S410
  • [45] Considerations When Initiating Psoriasis Patients on Biologic Therapy
    Zeichner, Joshua A.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (05) : S11 - S14
  • [46] Comparative Efficacy of Biologic Therapy in the Management of Biologic-Naive Patients With Ulcerative Colitis: An Indirect Treatment Comparison Meta-Analysis
    Singh, Siddharth
    Garg, Sushil Kumar
    Wang, Zhen
    Murad, Mohammad H.
    Loftus, Edward V.
    GASTROENTEROLOGY, 2014, 146 (05) : S384 - S384
  • [47] RESPONSE AND RADIOGRAPHIC PROGRESSION IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH SIRUKUMAB
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 723 - 723
  • [48] Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population
    Pappas D.A.
    Reed G.W.
    Saunders K.
    John A.
    Shewade A.
    Greenberg J.D.
    Kremer J.M.
    Rheumatology and Therapy, 2015, 2 (1) : 85 - 96
  • [49] Response and radiographic progression in biologic-naive and biologic-experienced patients with rheumatoid arthritis treated with sirukumab
    Thorne, C.
    Karpouzas, G.
    Takeuchi, T.
    Sheng, S.
    Xu, W.
    Xu, S.
    Kurrasch, R.
    Fei, K.
    Hsu, B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 23 - 24
  • [50] Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic-Naive Rheumatoid Arthritis Patients
    Kottak, Nicholas
    Tesser, John
    Leibowitz, Evan
    Rosenberg, Melissa
    Parenti, Dennis
    DeHoratius, Raphael
    ARTHRITIS CARE & RESEARCH, 2018, 70 (07) : 997 - 1004
12345